Orion Corporation
From Wikipedia, the free encyclopedia
| Orion Corporation | |
|---|---|
 |
|
| Type | Public (OMX: ORNBV) |
| Founded | 1917 |
| Headquarters | Espoo, Finland |
| Key people | Timo Lappalainen (President and CEO), Matti Kavetvuo (Chairman of the board) |
| Industry | Pharmaceutics |
| Products | Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests |
| Revenue | €683.6 million (2007)[1] |
| Operating income | ▲ €194 million (2007)[1] |
| Employees | 3,170 (2007)[1] |
| Website | www.orion.fi |
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company has also a large R&D unit in Turku.
Orion has annual net sales of approximately EUR 500 million; its class A and B shares are listed on the Helsinki Stock Exchange.
